Literature DB >> 7510964

Activation of macrophages by Alzheimer beta amyloid peptide.

A Klegeris1, D G Walker, P L McGeer.   

Abstract

Microglia (brain resident macrophages) have been found to be closely associated with beta amyloid containing plaques in brain tissue affected by Alzheimer disease (AD). To investigate whether beta amyloid peptide (beta AP) may activate microglia, the effects of synthetic beta AP (amino acids 1-40) and a subfragment (amino acids 25-35) on rat peritoneal macrophages were assessed using four different assays for activation. These peptides were compared with substance P, which has previously been shown to activate macrophages. Both beta amyloid peptides activated macrophages, as assessed by increased respiratory burst-associated oxygen consumption, by luminol-dependent chemiluminescence, and by aggregation. In addition, beta amyloid peptide (1-40) caused a significant increase in macrophage nitric oxide production, while subfragment (25-35) did not. Substance P caused significant activation as assessed by oxygen consumption and chemiluminescence, but not by aggregation or nitric oxide induction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7510964     DOI: 10.1006/bbrc.1994.1326

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

1.  A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.

Authors:  Maria E Bamberger; Meera E Harris; Douglas R McDonald; Jens Husemann; Gary E Landreth
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

2.  Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide.

Authors:  S Webster; B Bonnell; J Rogers
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

3.  Amyloid precursor protein expression modulates intestine immune phenotype.

Authors:  Kendra L Puig; Adam J Swigost; Xudong Zhou; Mary Ann Sens; Colin K Combs
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-29       Impact factor: 4.147

Review 4.  The multifaceted profile of activated microglia.

Authors:  Marina A Lynch
Journal:  Mol Neurobiol       Date:  2009-07-23       Impact factor: 5.590

5.  p75NTR antagonistic cyclic peptide decreases the size of beta amyloid-induced brain inflammation.

Authors:  Mina Yaar; Bennet L Arble; Kenneth B Stewart; Nazer H Qureshi; Neil W Kowall; Barbara A Gilchrest
Journal:  Cell Mol Neurobiol       Date:  2008-09-19       Impact factor: 5.046

6.  Do nonsteroidal anti-inflammatory drugs have a protective effect against dementia?

Authors:  F L Van Muiswinkel; P Eikelenboom
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

Review 7.  The future use of complement inhibitors for the treatment of neurological diseases.

Authors:  E G McGeer; P L McGeer
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

8.  Prostaglandins act as neurotoxin for differentiated neuroblastoma cells in culture and increase levels of ubiquitin and beta-amyloid.

Authors:  K N Prasad; F G La Rosa; J E Prasad
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-03       Impact factor: 2.416

9.  Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.

Authors:  Jaewon Lee; Sic L Chan; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

10.  Aggregates of denatured proteins stimulate nitric oxide and superoxide production in macrophages.

Authors:  Szczepan Jozefowski; Janusz Marcinkiewicz
Journal:  Inflamm Res       Date:  2009-09-26       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.